| dc.contributor.author | Corley, EA | |
| dc.contributor.author | Pace, E | |
| dc.contributor.author | Barnacle, AM | |
| dc.contributor.author | Patel, PA | |
| dc.contributor.author | Thway, K | |
| dc.contributor.author | Chisholm, JC | |
| dc.coverage.spatial | United States | |
| dc.date.accessioned | 2023-02-14T13:48:14Z | |
| dc.date.available | 2023-02-14T13:48:14Z | |
| dc.date.issued | 2023-01-16 | |
| dc.identifier | 00043426-990000000-00171 | |
| dc.identifier.citation | Journal of Pediatric Hematology/Oncology, 2023, Publish Ahead of Print | en_US |
| dc.identifier.issn | 1077-4114 | |
| dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/5689 | |
| dc.identifier.eissn | 1536-3678 | |
| dc.identifier.eissn | 1536-3678 | |
| dc.identifier.doi | 10.1097/MPH.0000000000002612 | |
| dc.description.abstract | Angiomatoid fibrous histiocytoma (AFH) is a soft tissue neoplasm of intermediate biological potential. Typically a slow-growing tumor, it can recur locally. Rarely, it manifests as a soft tissue sarcoma capable of metastasis. When metastases are nonamenable to local therapy, it is believed uniformly fatal. We present 3 patients with metastatic AFH who demonstrated a sustained response to chemotherapy; including one who achieved complete remission with cryoablation. These cases reinforce the potential value of chemotherapy in some patients with unresectable metastatic AFH and provide the first case in the literature of cryoablation in AFH. | en_US |
| dc.format | Print-Electronic | |
| dc.language | eng | |
| dc.language.iso | eng | en_US |
| dc.publisher | Ovid Technologies (Wolters Kluwer Health) | en_US |
| dc.relation.ispartof | Journal of Pediatric Hematology/Oncology | |
| dc.rights.uri | http://www.rioxx.net/licenses/all-rights-reserved | en_US |
| dc.title | Evidence of Chemoresponsiveness in Unresectable Metastatic Angiomatoid Fibrous Histiocytoma. | en_US |
| dc.type | Journal Article | |
| dcterms.dateAccepted | 2022-11-13 | |
| dc.date.updated | 2023-02-13T22:30:56Z | |
| rioxxterms.version | AM | en_US |
| rioxxterms.versionofrecord | 10.1097/MPH.0000000000002612 | en_US |
| rioxxterms.licenseref.startdate | 2023-01-16 | |
| rioxxterms.type | Journal Article/Review | en_US |
| pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/36716049 | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials in Children and Young People | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Sarcoma Clinical Trials in children and young people | |
| pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials in Children and Young People/Sarcoma Clinical Trials in Children and Young People (hon.) | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Sarcoma Clinical Trials in children and young people/Sarcoma Clinical Trials in Children and Young People (hon.) | |
| pubs.publication-status | Published online | |
| pubs.publisher-url | http://dx.doi.org/10.1097/mph.0000000000002612 | |
| pubs.volume | Publish Ahead of Print | |
| dc.contributor.icrauthor | Chisholm, Julia | |
| icr.provenance | Deposited by Dr Julia Chisholm on 2023-02-13. Deposit type is initial. No. of files: 1. Files: JPHO-21-720_EC_answers[1].pdf | |
| icr.provenance | Deposited by Mr Arek Surman (impersonating Dr Julia Chisholm) on 2023-02-14. Deposit type is subsequent. No. of files: 1. Files: JPHO-21-720_E.pdf | |
